Latest News and Press Releases
Want to stay updated on the latest news?
-
MediPharm Labs is pleased to announce the completion of the Company's first shipment to France.
-
TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based...
-
MediPharm delivered another successful quarter of strong year-over-year revenue growth in the three months ended September 30, 2025 ("Q3 2025").
-
MediPharm will release its third quarter financial results before markets open on Thursday, November 13th, 2025.
-
MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis.
-
MediPharm announces it will release its second quarter 2025 financial results before markets open on Thursday, August 14th, 2025.
-
MediPharm Labs Launches New Shake & Puff CBN THC Nighttime Metered Dose Inhaler in Canada.
-
MediPharm Announces Election of All Seven Company Director Nominees at 2025 Annual and Special Meeting of Shareholders.
-
TORONTO, June 16, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based...
-
Independent proxy advisor Glass Lewis recommends that MediPharm shareholders vote for all of the Company's director nominees.